Previous studies found that SAA can promote atherosclerosis development by recruiting monocytes and polymorphonuclear leukocytes [10], increasing HDL binding to macrophages and endothelial cells [11], inducing endothelial dysfunction [12], and lessening VSMC lipid biosynthesis [13]. The gene discussed is SAA2; the disease is endothelial dysfunction.